February 21, 2023

BTS, a world-leading strategy implementation firm based out of Stockholm, Sweden, has joined the Cincinnati Innovation District as a corporate partner. The company will locate its global innovation, digital transformation, and environmental, social and corporate governance (ESG) center within the University of Cincinnati 1819 Innovation Hub, the nerve center of the CID.

February 28, 2023

On a chilly winter day just before noon, corporate partners and staff at the University of Cincinnati’s 1819 Innovation Hub took a break from their workday to prioritize their mental well-being.

September 12, 2022

Technology from a University of Cincinnati Venture Lab-backed startup could save lives by allowing emergency medical personnel to accurately monitor the life-saving treatment they provide.

July 21, 2022

The University of Cincinnati is poised to welcome its largest class ever this fall, for which UC President Neville G. Pinto credits the entire university community.

August 17, 2022

When the University of Cincinnati’s Esports Innovation Lab opens Aug. 18, it will be more than just a space for competitive online gaming.

August 16, 2022

A University of Cincinnati Venture Lab-backed startup is looking to reinvent the physical therapy market with a new approach that offers hope for a more effective and more convenient way to provide treatment.

August 19, 2022

Leadership announcement

September 23, 2022

The University of Cincinnati celebrated the grand opening of its Digital Futures building, a facility for interdisciplinary research, on Friday in the Cincinnati Innovation District.

October 7, 2022

A University of Cincinnati Venture Lab-backed startup has begun its efforts to rid waterways of plastic pollution by launching its first autonomous rover at Point San Pablo Harbor near San Francisco.

October 7, 2022

A University of Cincinnati Venture Lab-backed startup is developing a breast cancer treatment that may be more effective with fewer side effects thanks to RNA nanotechnology that is similar to what was used to produce COVID-19 vaccines.